Monday, October 07, 2019

Yet another mostly male microbiome meeting - #YAMMMM - a microbiome #manel in San Diego





Well, just when I thought the microbiome space was getting better about diversity of speakers.  I got called twice today from someone trying to get me to sign up for this meeting and I got an email about it too.

The meeting: "Gen-Next Probiotics and Microbiome - Advanced Therapeutics and Sequencing Congress” to be held on 6th and 7th February 2020 in San Diego, USA."

Speakers from the email:
• Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech
• Bharath Prithiviraj, Senior Scientist, City university of New York
• Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals
• Seth Crosby, Director, Research Collaborations, Washington University School of Medicine
• Elliot Friedman, Senior Research Investigator, University of Pennsylvania
• Peter Leighton, CEO, ProSperity Bioscience
• Tal Korem, Assistant Professor, Columbia University in New York City
• Chuck Collins, Professor, East Tennessee State University
• Joseph C Ellis, Sr. Staff Scientist, OAK Ridge National Laboratory
• Aubrey Levitt, CEO/Co-Founder, Postbiotics +
• M. Andrea Azcarate-Peril, Director, Microbiome Core Facility, University of North Carolina
• Arun Bhunia, Professor of Food Microbiology, Purdue University
• A. Bruce Johnson, PhD, Corporate Vice President, Business Development, Phibro Animal Health Corporation
• Michael Leonidas Chikindas, Microbiologist, Rutgers University

I looked up these people and their descriptions on various websites and with this information and other I assigned them to M vs F.  I realize this approach is imperfect.  I label my inferences below: M in yellow and F in green.

Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech
Bharath Prithiviraj, Senior Scientist, City university of New York
Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals
• Seth Crosby, Director, Research Collaborations, Washington University School of Medicine
• Elliot Friedman, Senior Research Investigator, University of Pennsylvania
• Peter Leighton, CEO, ProSperity Bioscience
• Tal Korem, Assistant Professor, Columbia University in New York City
• Chuck Collins, Professor, East Tennessee State University
• Joseph C Ellis, Sr. Staff Scientist, OAK Ridge National Laboratory
Aubrey Levitt, CEO/Co-Founder, Postbiotics +
• M. Andrea Azcarate-Peril, Director, Microbiome Core Facility, University of North Carolina
• Arun Bhunia, Professor of Food Microbiology, Purdue University
• A. Bruce Johnson, PhD, Corporate Vice President, Business Development, Phibro Animal Health Corporation
• Michael Leonidas Chikindas, Microbiologist, Rutgers University

So that comes to 11M vs 3F.

Or ~ 80% M.

No thanks.  I will skip this YAMMMM.  And you should too. 


No comments:

Post a Comment